Cite
Zachwieja J, Silska-Dittmar M, Żurowska A, et al. Multicenter analysis of the efficacy and safety of a non-standard immunosuppressive therapy with rituximab in children with steroid-resistant nephrotic syndrome. Clin Exp Pharmacol Physiol. 2018;46(4):313-321doi: 10.1111/1440-1681.13046.
Zachwieja, J., Silska-Dittmar, M., Żurowska, A., Drożyńska-Duklas, M., Hyla-Klekot, L., Kucharska, G., Stankiewicz, R., Olszak-Szot, I., Drożdż, D., Moczulska, A., Zwolińska, D., Medyńska, A., Sikora, P., Bieniaś, B., Tkaczyk, M., Rogowska-Kalisz, A., & Ostalska-Nowicka, D. (2019). Multicenter analysis of the efficacy and safety of a non-standard immunosuppressive therapy with rituximab in children with steroid-resistant nephrotic syndrome. Clinical and experimental pharmacology & physiology, 46(4), 313-321. https://doi.org/10.1111/1440-1681.13046
Zachwieja, Jacek, et al. "Multicenter analysis of the efficacy and safety of a non-standard immunosuppressive therapy with rituximab in children with steroid-resistant nephrotic syndrome." Clinical and experimental pharmacology & physiology vol. 46,4 (2019): 313-321. doi: https://doi.org/10.1111/1440-1681.13046
Zachwieja J, Silska-Dittmar M, Żurowska A, Drożyńska-Duklas M, Hyla-Klekot L, Kucharska G, Stankiewicz R, Olszak-Szot I, Drożdż D, Moczulska A, Zwolińska D, Medyńska A, Sikora P, Bieniaś B, Tkaczyk M, Rogowska-Kalisz A, Ostalska-Nowicka D. Multicenter analysis of the efficacy and safety of a non-standard immunosuppressive therapy with rituximab in children with steroid-resistant nephrotic syndrome. Clin Exp Pharmacol Physiol. 2019 Apr;46(4):313-321. doi: 10.1111/1440-1681.13046. Epub 2018 Dec 13. PMID: 30346047.
Copy
Download .nbib